| Subject: | FDA Approves New Medical Device to Treat Thoracic Aneurysms |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 5 Apr 2005 - 10:00 am |
| The FDA has approved the Gore Tag Endoprosthesis System, manufactured by W.L. Gore and Associates, Inc, and is an endovascular grafting device for the treatment of thoracic aneurysms. Thoracic aneurysms involve the descending thoracic aorta and are an enlargement of a weakened area of the thoracic portion of the aorta. Aneurysms in this area are prone to rupture once they reach a certain size. Approximately fifty percent of patients who experience a rupture of a thoracic aortic aneurysm die... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
